CRISPR sheds light on rare pediatric bone marrow failure syndrome | The Source | Washington University in St. Louis
Using the gene editing technology CRISPR, scientists at the School of Medicine have shed light on a rare, sometimes fatal syndrome that causes children to gradually lose the ability to manufacture vital blood cells.